Center for Inquiry Inc. v. Walmart, Inc.

Center for Inquiry Inc. v. Walmart, Inc. William M. Janssen* I. Why It Made the List “Get ready to match the stars—as we play the star-studded, big money Match Game! And here’s your host, Gene Rayburn!” Anyone born in the 1960s likely remembers this TV opening with its funky, synthesized musical theme, opening each [...]

Center for Inquiry Inc. v. Walmart, Inc.2023-06-22T14:15:25-04:00

Recent Cases on “Green” Messaging in Food and Beverage Company Advertising

Recent Cases on “Green” Messaging in Food and Beverage Company Advertising Rene Befurt, Anne Cai, Rebecca Kirk Fair & Helene Rowland* I. Why They Made the List Several recent lawsuits around “green” messaging in company advertising raise the question of how we can reliably evaluate “reasonable” consumers’ understanding of or reactions to sustainability or [...]

Recent Cases on “Green” Messaging in Food and Beverage Company Advertising2023-06-22T14:15:50-04:00

Defendants Beware: Did the Sixth Circuit Just Make Prescriber Testimony Irrelevant in Failure to Warn Cases?

Defendants Beware: Did the Sixth Circuit Just Make Prescriber Testimony Irrelevant in Failure to Warn Cases? Anand Agneshwar & Jocelyn Wiesner* I. Why It Made the List It is axiomatic that a plaintiff bears the burden of proof on each element of her claim. In pharmaceutical and medical device failure to warn claims, this [...]

Defendants Beware: Did the Sixth Circuit Just Make Prescriber Testimony Irrelevant in Failure to Warn Cases?2023-06-22T14:16:22-04:00

Significant Digital Health and Cybersecurity Regulatory Developments, 2022

Significant Digital Health and Cybersecurity Regulatory Developments, 2022 Stephanie Philbin, Steven Tjoe & Lauren Farruggia* Throughout 2022, the U.S. Food and Drug Administration (FDA or the agency) continued to refine its frameworks for oversight of the digital health and broader device industry with important regulatory updates impacting device software and cybersecurity. The Food and [...]

Significant Digital Health and Cybersecurity Regulatory Developments, 20222023-06-22T14:21:04-04:00

2022 Significant Settlements

2022 Significant Settlements Vanessa K. Fulton* I. Introduction This chapter summarizes a selection of significant settlements (including non-litigated resolutions such as criminal plea bargains or agency consent orders) in 2022 between members of the food and drug industry and government agencies, such as the U.S. Food and Drug Administration (FDA) and the U.S. Department [...]

2022 Significant Settlements2023-06-22T14:16:38-04:00

Food and Drug Cases to Watch in 2023

Food and Drug Cases to Watch in 2023* We asked our Top Cases chapter authors for their picks on which current litigations, regulatory actions, and other developments have the potential to change the food and drug landscape in the balance of 2023. Some of the cases described here are appeals or other forms of [...]

Food and Drug Cases to Watch in 20232023-06-22T14:16:55-04:00

Food and Drug Law Journal 2023 Symposium Agenda

Why Attend Agenda Location & CLE Agenda Subject to Change All Times Listed in Eastern Time Wednesday, November 8 Paige Samson, Director, Innovative Programs and Publications, FDLI Alan G. Minsk, Partner, Arnall Golden Gregory LLP Authors: Sonia Nath, Partner; Natasha V. Leskovsek, Of [...]

Food and Drug Law Journal 2023 Symposium Agenda2023-11-07T16:04:20-05:00

Introduction to Advertising and Promotion for Medical Products Agenda Fall 2023

Why Attend  Agenda Location & CLE All times are in Eastern Time 2023 Curriculum Advisor:  Georgia C. Ravitz, Partner, Wilson Sonsini Goodrich & Rosati Wednesday, November 1 11:30 AM–12:00 PM Registration and Lunch 12:00–12:10 PM Welcome and Course Overview Khara L. Minter, Assistant Director, Training Programs, [...]

Introduction to Advertising and Promotion for Medical Products Agenda Fall 20232023-10-31T16:04:04-04:00
Go to Top